Understanding connections and roles of gut microbiome in cardiovascular diseases

The gut microbiome encompasses trillions of residing microbes, mainly bacteria, which play a crucial role in maintaining the physiological and metabolic health of the host. The gut microbiome has been associated with several diseases, including cardiovascular disease (CVD). A growing body of evidence suggests that an altered gut environment and gut-microbiome-derived metabolites are associated with CVD events. The gut microbiome communicates with host physiology through different mechanisms, including trimethylamine N-oxide generation, primary and secondary bile acid metabolism pathways, and short-chain fatty acids production. The main focus of this review is to understand the association of the gut microbiome with CVD and its implications on the interactions between the gut microbiome and the host. Manipulation of the gut microbiome through specific dietary intervention is a simple approach to identifying novel targets for therapy or better dietary recommendations, and new preventive measures for screening biomarkers to reduce CVD risk in humans.

Automated summary

The gut microbiome, composed of trillions of residing bacteria, plays a crucial role in maintaining the physiological and metabolic health of the host, and has been associated with diseases like cardiovascular disease. Evidence suggests that altered gut environment and microbiome-derived metabolites are linked to CVD events. By manipulating the gut microbiome through dietary intervention, novel therapy targets, dietary recommendations, and preventive measures can be identified to reduce CVD risk in humans.